BSC
QTTB icon

BOLTON SECURITIES CORPORATION’s Q32 Bio QTTB Stock Holding History

BOLTON SECURITIES CORPORATION’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$66.2K Sell
8,000
-2,000
-20% -$27.7K ﹤0.01% 1252
2026
Q2 		$127K Buy
+10,000
New +$83.6K ﹤0.01% 1042

Other funds holding QTTB

Atlas Venture Life Science Advisors
Atlas Venture Life Science Advisors Cambridge, Massachusetts $631M AUM 38.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
Sanofi
Sanofi Paris, France $630M AUM 104.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return

BOLTON SECURITIES CORPORATION's QTTB Position: Q3 2026 in Review

BOLTON SECURITIES CORPORATION reduced its Q32 Bio (QTTB) stake by 20% in Q3 2026, selling an estimated $27.7K and leaving 8,000 shares worth $66.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1252.

BOLTON SECURITIES CORPORATION first reported a position in QTTB in Q2 2026 and has held it in 2 quarters since. The position peaked at $127K in Q2 2026. 38 funds tracked by Wall St. Rank hold QTTB as of Q3 2026.

  • BOLTON SECURITIES CORPORATION held 8,000 shares of Q32 Bio worth $66.2K as of Q3 2026.
  • BOLTON SECURITIES CORPORATION sold 2,000 Q32 Bio shares in Q3 2026, an estimated $27.7K.
  • Q32 Bio made up ﹤0.01% of BOLTON SECURITIES CORPORATION's portfolio in Q3 2026, its #1252 holding.
  • BOLTON SECURITIES CORPORATION first reported a position in Q32 Bio in Q2 2026 and has held it in 2 quarters since.
  • BOLTON SECURITIES CORPORATION's Q32 Bio position peaked at $127K in Q2 2026.
  • 38 funds tracked by Wall St. Rank held Q32 Bio as of Q3 2026.

Based on BOLTON SECURITIES CORPORATION's 13F filing for Q3 2026, filed 12 Nov 2026.